WINDLAS BIOTECH
|
WINDLAS BIOTECH Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 29.10 | 27.98 | 20.37 | 17.48 | 24.70 |
| CEPS(Rs) | 42.45 | 34.44 | 26.28 | 23.05 | 15.67 |
| DPS(Rs) | 5.80 | 5.50 | 4.00 | 3.50 | - |
| Book NAV/Share(Rs) | 238.80 | 213.99 | 190.89 | 180.31 | 310.59 |
| Tax Rate(%) | 23.53 | 24.52 | 25.27 | 16.41 | 28.38 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 12.38 | 12.39 | 11.74 | 11.25 | 12.79 |
| EBIT Margin(%) | 11.07 | 12.39 | 11.27 | 10.08 | 5.39 |
| Pre Tax Margin(%) | 10.50 | 12.22 | 11.12 | 9.78 | 5.08 |
| PAT Margin (%) | 8.03 | 9.22 | 8.31 | 8.17 | 3.64 |
| Cash Profit Margin (%) | 11.71 | 11.35 | 10.72 | 10.78 | 6.67 |
| Performance Ratios | |||||
| ROA(%) | 8.80 | 10.10 | 8.39 | 9.70 | 4.91 |
| ROE(%) | 12.90 | 13.78 | 10.76 | 12.87 | 7.62 |
| ROCE(%) | 17.12 | 18.34 | 14.39 | 14.88 | 9.85 |
| Asset Turnover(x) | 1.10 | 1.09 | 1.01 | 1.19 | 1.35 |
| Sales/Fixed Asset(x) | 2.45 | 2.69 | 2.87 | 2.68 | 3.24 |
| Working Capital/Sales(x) | 2.76 | 2.43 | 2.21 | 1.62 | 4.24 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.41 | 0.37 | 0.35 | 0.37 | 0.31 |
| Receivable days | 72.81 | 73.22 | 80.97 | 74.49 | 61.18 |
| Inventory Days | 34.48 | 39.61 | 47.47 | 39.24 | 38.74 |
| Payable days | 120.16 | 106.89 | 92.18 | 64.78 | 85.92 |
| Valuation Parameters | |||||
| PER(x) | 35.78 | 18.31 | 11.06 | 12.02 | - |
| PCE(x) | 24.53 | 14.88 | 8.57 | 9.11 | - |
| Price/Book(x) | 4.36 | 2.39 | 1.18 | 1.17 | - |
| Yield(%) | 0.56 | 1.07 | 1.78 | 1.67 | - |
| EV/Net Sales(x) | 2.89 | 1.64 | 0.87 | 0.75 | 0.02 |
| EV/Core EBITDA(x) | 19.56 | 11.29 | 6.36 | 5.92 | 0.11 |
| EV/EBIT(x) | 26.07 | 13.23 | 7.72 | 7.45 | 0.29 |
| EV/CE(x) | 4.12 | 2.30 | 1.11 | 0.72 | 0.02 |
| M Cap / Sales | 2.87 | 1.69 | 0.92 | 0.98 | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 20.43 | 22.97 | 10.12 | 8.96 | 30.03 |
| Core EBITDA Growth(%) | 22.35 | 30.56 | 18.71 | 2.33 | 31.47 |
| EBIT Growth(%) | 7.60 | 35.22 | 23.08 | 104.00 | -15.31 |
| PAT Growth(%) | 4.82 | 36.51 | 11.91 | 144.63 | -3.97 |
| EPS Growth(%) | 4.01 | 37.35 | 16.55 | -29.23 | -2.35 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.05 | - | - | 0.02 | 0.16 |
| Current Ratio(x) | 2.11 | 2.51 | 2.92 | 4.06 | 2.08 |
| Quick Ratio(x) | 1.78 | 2.15 | 2.30 | 3.44 | 1.64 |
| Interest Cover(x) | 19.20 | 70.77 | 73.38 | 33.16 | 17.85 |
| Total Debt/Mcap(x) | 0.01 | - | - | 0.01 | - |
Compare Financial Ratios of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,662.8 Cr | -0.7% | -18% | -28.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,248.0 Cr | -0.2% | 5.8% | 0.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,344.0 Cr | -0.6% | -5.2% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,832.0 Cr | -0.5% | 2.5% | 12.1% | Stock Analytics | |
| CIPLA | ₹121,820.0 Cr | -1.1% | -0.2% | -1.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,877.0 Cr | 2.4% | 7% | 6.2% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | -0.7% |
-18% |
-28.6% |
| SENSEX | -0.6% |
1.4% |
7.7% |
You may also like the below Video Courses
